Amanote Research
Register
Sign In
Phase I–II Evaluation of Rapid Sequence Tandem High-Dose Melphalan With Peripheral Blood Stem Cell Support in Patients With Multiple Myeloma
Bone Marrow Transplantation
- United Kingdom
doi 10.1038/sj.bmt.1701324
Full Text
Open PDF
Abstract
Available in
full text
Categories
Transplantation
Hematology
Date
August 1, 1998
Authors
CH Weaver
B Zhen
LS Schwartzberg
R Leff
M Magee
L Geier
K Deaton
L Lewkow
CD Buckner
Publisher
Springer Science and Business Media LLC
Related search
A Randomized Placebo-Controlled Phase II Study of Clarithromycin or Placebo Combined With VCD Induction Therapy Prior to High-Dose Melphalan With Stem Cell Support in Patients With Newly Diagnosed Multiple Myeloma
Experimental Hematology and Oncology
Cancer Research
Oncology
Hematology
Evaluation of High-Dose Melphalan Toxicity by Age in Patients Undergoing Autologous Stem Cell Transplant for Multiple Myeloma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
A Phase I Dose Escalation Study of High-Dose Thiotepa, Melphalan and Carboplatin (TMCb) Followed by Autologous Peripheral Blood Stem Cell Transplantation (PBSCT) in Patients With Solid Tumors and Hematologic Malignancies
Bone Marrow Transplantation
Transplantation
Hematology
Allogeneic Transplantation of Unmanipulated Peripheral Blood Stem Cells in Patients With Multiple Myeloma
Bone Marrow Transplantation
Transplantation
Hematology
High-Dose BCNU/Melphalan Conditioning Regimen Before Autologous Stem Cell Transplantation in Newly Diagnosed Multiple Myeloma
Bone Marrow Transplantation
Transplantation
Hematology
Phase I Study of Tandem High-Dose Chemotherapy With Autologous Peripheral Blood Stem Cell Rescue for Children With Recurrent Brain Tumors: A Pediatric Blood and Marrow Transplant Consortium Study
Pediatric Blood and Cancer
Oncology
Child Health
Hematology
Perinatology
Medicine
Pediatrics
MBL2 Polymorphism and Risk of Severe Infections in Multiple Myeloma Patients Receiving High-Dose Melphalan and Autologous Stem Cell Transplantation
Bone Marrow Transplantation
Transplantation
Hematology
Comparison of Peripheral Blood Progenitor Cell Mobilization in Patients With Multiple Myeloma: High-Dose Cyclophosphamide Plus GM-CSF vs G-CSF Alone
Bone Marrow Transplantation
Transplantation
Hematology
High-Dose Chemotherapy With Peripheral Blood Stem Cell Support for Stage IIIB Inflammatory Carcinoma of the Breast
Bone Marrow Transplantation
Transplantation
Hematology
